Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. META

Go back to Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity

Alnylam Pharmaceuticals (ALNY) PT Lowered to $142 at Piper Jaffray

February 8, 2019 8:51 AM EST

Piper Jaffray analyst Edward Tenthoff lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $142.00 (from $152.00) while maintaining a Overweight rating.

... More

Alnylam Pharma (ALNY) Tops Q4 EPS by 19c

February 7, 2019 4:14 PM EST

Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($2.09), $0.19 better than the analyst estimate of ($2.28). Revenue for the quarter came in at $21.03 million versus the consensus estimate of $15.12 million.

For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.

... More